Cardiff Oncology Inc. sell Global_Player
Start price
31.08.20
/
50%
€6.70
Target price
03.09.20
€6.00
Performance (%)
-11.94%
End price
03.09.20
€5.90
Summary
This prediction ended on 03.09.20 with a price of €5.90. The price of Cardiff Oncology Inc. decreased from the start of the prediction. Compared to the start price this resulted in a performance of -11.94%. Global_Player has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Cardiff Oncology Inc. | -7.583% | -7.583% | 193.675% | -42.222% |
| iShares Core DAX® | 1.804% | -0.748% | 13.168% | 16.408% |
| iShares Nasdaq 100 | -0.182% | -3.412% | 39.976% | 43.502% |
| iShares Nikkei 225® | 0.413% | -7.381% | 18.776% | 2.874% |
| iShares S&P 500 | 0.664% | -1.941% | 28.141% | 42.155% |
According to Global_Player what are the pros and cons of Cardiff Oncology Inc. for the foreseeable future?
Pros
Cons
Risky Investment
Comments by Global_Player for this prediction
In the thread Trovagene diskutieren
Sell mit Kursziel 6,0
In the thread Trading Trovagene
Stopped prediction by Global_Player for Cardiff Oncology Inc.
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€1.24
17.11.22
17.11.22
-
17.11.23
17.11.23
0.48%
26.12.22
26.12.22
Risky Investment
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€1.65
18.09.22
18.09.22
-
18.09.23
18.09.23
-3.77%
01.10.22
01.10.22
Risky Investment
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€6.00
17.01.22
17.01.22
-
17.01.23
17.01.23
-44.67%
22.01.22
22.01.22
Risky Investment